Clinical Trials Browser

Observational × blinatumomab × Other hematologic neoplasm × Clear all

NCT06649422 2024-10-18

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Not yet recruiting

Other hematologic neoplasm

Leukemia

NCT06075212 2023-10-10

Immune Reconstitution After Allo-HSCT and Blinatumomab

Other hematologic neoplasm

Leukemia, Lymphoid

NCT03318770 2022-10-12

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma